STEFANI ALVAREZ: Open Payments
NPI 1245837962 · FORT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,316 in 90 payments from 18 companies in 2025. Trend: 2023 $844 · 2024 $1,611 · 2025 $2,316
Food & beverage: $2,216Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $359 |
| Janssen Biotech, Inc. | 16 | $323 |
| ABBVIE INC. | 16 | $271 |
| GENZYME CORPORATION | 6 | $251 |
| Galderma Laboratories, L.P. | 5 | $209 |
| Incyte Corporation | 4 | $203 |
| Amgen Inc. | 5 | $170 |
| UCB, Inc. | 4 | $101 |
| PFIZER INC. | 4 | $96 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $77 |
Products named: TREMFYA, DUPIXENT, Opzelura, COSENTYX, SKYRIZI, NEMLUVIO, Bimzelx, CIBINQO.
Industry payments across FL — which companies pay providers there.
